FDA Medical Device Software Regulation Strategy Seminar: Philadelphia, PA, United States - November 7-8, 2019
Sep 19, 2019, 14:15 ET
DUBLIN, Sept. 19, 2019 /PRNewswire/ -- The "FDA's Medical Device Software Regulation Strategy" conference has been added to ResearchAndMarkets.com's offering.
This seminar will focus on addressing these concerns and educating participants on FDA's recent medical device software regulation strategies.
Agenda:
Day 1
FDA Authority and Regulatory Program
- Types of Software Devices
- Regulatory Strategy
- Risk Classification
- Function and outcome
- Medical Device Data Systems (MDDS)
- Office of the National Coordinator (ONC) for Health Information Protection
- Software Regulatory Applications
- FDA Guidance
- Premarket submissions
- Paradigms: aeronautics
- Quality System Regulation (QSR)
- Design verification and validation
- Voluntary standards
- Corrective and prevent action plans
- Voluntary Standards
- Recalls:
- Service / maintenance / recall
- Implementation strategy
- Corrections and Removals Reporting
- Updates: FDA vs. Non-FDA
- Predictive Analytics
Interoperability
- Compatibility by Design
- Hardware
- Software
- Labeling
- Precautions
- Instructions for use
- Use of Voluntary Standards
- Proprietary Information
- Failure Management / Follow Up
- User's vs. Manufacturer's Legal Responsibility
- System configuration
- Customization
- Environment of use
- Professional
- Home use
Day 2
Cybersecurity
- Device Vulnerabilities: Malfunction and Failure
- Pre-Emption Design
- Latent Malware/Virus
- Post-Event Management
- Corrective action for software
- Disclosure to users
- National Institute of Science and Technology Report
Medical Mobile Applications (Mobile Apps)
- Mobile Apps Defined as a Device
- FDA Regulatory Strategy
- FDA Guidance
- National Institute of Science and Technology Report and Collaboration
- Updates (FDA vs. Non-FDA Updates)
- Criteria for corrective and preventive action deemed recalls
- Reports of corrections and removals
- Reports of adverse events
- Professional vs. Lay Use / Home Use
- Labeling: Instructions for Use and Precautions
- Environment of Use
- FDA Regulation of Accessories
- Federal Communications Commission (FCC) Regulation
The growth of the medical software industry outpaces the design of FDA's regulatory process. In some instances clinicians have weighed the risk of software failure against the benefits of using a device at all. Device software is often used in conjunction with other software-based devices, but their interoperability was never anticipated.
- How can you anticipate and defend against the malicious remote hacking and shut down of an insulin infusion pump?
- Can one software program defeat the performance capability or back up safety features of another software program?
- When interoperability surface, which software manufacturer takes the lead to solve the problem and deal with proprietary software issues?
Seminar instructor Casper Uldriks is an ex-FDA official who has spent 32 years with the FDA. His engagements focus on advertising and promotion, recalls, corrections and removals and enforcement. He currently trains FDA personnel and counsels clients on wide range of topics, including: FDA inspections; import operations; advertising and promotion; corrective and preventive actions; medical device reporting and corporate reorganization to improve conformance to FDA's requirements.
The medical device trade and healthcare professionals remain plagued by other issues, such as the interoperability of devices from different manufacturers, or software validation that is limited to the immediate use of the software rather than its performance with other software programs, and software hacking protection applications. In case of software malfunction, fixing the malfunction or bug can get more difficult as software gets increasingly sophisticated, customized by users and placed in a network system. Under these circumstances, it is difficult to decide who is responsible for managing and fixing software problems.
This seminar will help those involved in overcoming these commercial and regulatory obstacles. It will highlight the need for firms to remain current with technological tools and strategy to remain competitive, and ideally, outside FDA's regulatory radar.
Going further, it will instruct participants on how to apply these tools and strategies to ensure the following factors:
- Software functionality
- Risk identification
- Software protection
- Problem detection
- Response strategy
For those who have addressed these issues to meet FDA's regulatory expectations, the course instructor, a former FDA official, will help identify a basic centering point to build a regulatory profile for your software products.
Learning Objectives:
- Understanding FDA legal authority
- Applying FDA classifications / risk controls
- Understanding FDA and NIST software guidance
- Identifying the quality system regulation for risk management, software verification and validation
- Identifying cybersecurity issues and developing a planned response
- Identifying and resolving interoperability issues
- Figuring out the scope of FDA's mobile apps regulation
- Learning about bug updates classified as recalls by FDA
- Future device software applications
Who Should Attend:
Who Will Benefit:
- Regulatory Affairs Managers
- Quality Assurance Managers
- Software Design Engineers
- Manufacturing Managers
- Compliance Department Personnel
- Hospital Risk Department Personnel
- Software Program Marketers
- IT Security Managers
- Marketing Personnel
For more information about this conference visit https://www.researchandmarkets.com/r/j1dro9
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
